Singular Genomics Systems, Inc. Common Stock
OMIC
OMIC was delisted on the 20th of February, 2025.
74 hedge funds and large institutions have $99.2M invested in Singular Genomics Systems, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 25 increasing their positions, 19 reducing their positions, and 14 closing their positions.
32% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 19
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
3% less funds holding
Funds holding: 76 → 74 (-2)
14% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 14
33% less capital invested
Capital invested by funds: $147M → $99.2M (-$47.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$2.58M |
| 2 |
CC
Casdin Capital
New York
|
+$1.67M |
| 3 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
+$1.57M |
| 4 |
KeyBank National Association
Cleveland,
Ohio
|
+$1.23M |
| 5 |
BlackRock
New York
|
+$1.08M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Alphabet Inc
Mountain View,
California
|
-$2.24M |
| 2 |
UBS AM
Chicago,
Illinois
|
-$1.12M |
| 3 |
D.E. Shaw & Co
New York
|
-$627K |
| 4 |
Two Sigma Investments
New York
|
-$622K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$588K |
OMIC Hedge Fund Activity: Q3 2022 in Review
74 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Singular Genomics Systems, Inc. Common Stock (OMIC) for Q3 2022, worth a combined $99.2M — down 33% from $147M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of OMIC and 12 opened new positions — a net loss of 2 holders — while 19 trimmed existing stakes and 25 added.
The largest buyer was Deerfield Management, adding an estimated $2.58M. The largest seller was Alphabet Inc, exiting entirely with an estimated $2.24M sold.
- 74 institutional investors held Singular Genomics Systems, Inc. Common Stock (OMIC) as of Q3 2022, down from 76 in Q2 2022.
- Funds reported $99.2M of Singular Genomics Systems, Inc. Common Stock stock for Q3 2022, down 33% quarter-over-quarter.
- 12 funds opened new Singular Genomics Systems, Inc. Common Stock positions in Q3 2022 and 14 closed out, a net change of -2 holders.
- The largest Singular Genomics Systems, Inc. Common Stock buyer in Q3 2022 was Deerfield Management, an estimated $2.58M added.
- The largest Singular Genomics Systems, Inc. Common Stock seller in Q3 2022 was Alphabet Inc, an estimated $2.24M sold.
Based on aggregated 13F filings for Q3 2022.